Evidence map›Paper›PMID 38384895›Full record

ArticleJournal of clinical and translational science2024

Novel recruitment approaches and operational results for a statewide population Cohort for cancer research: The Healthy Oregon Project.

Zhenzhen Zhang, Autumn Shafer, Katie Johnson-Camacho, Andrew Adey, Pavana Anur, Kim A Brown, Casey Conrad, Rachel Crist, Paige E Farris, Christina A Harrington and 7 more

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Zhenzhen ZhangDivision of Oncological Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.ORCID https://orcid.org/0000-0002-9440-3892
Autumn ShaferSchool of Journalism and Communication, University of Oregon, Eugene, OR, USA.
Katie Johnson-CamachoDepartment of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Andrew AdeyDivision of Oncological Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Pavana AnurCancer Early Detection Advanced Research Center, Oregon Health and Science University, Portland, OR, USA.
Kim A BrownKnight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Casey ConradKnight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Rachel CristKnight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Paige E FarrisKnight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Christina A HarringtonDepartment of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, USA.
Lisa K MarriottOHSU-PSU School of Public Health, Oregon Health & Science University, Portland, OR, USA.
Asia MitchellDepartment of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, USA.
Brian O'RoakDepartment of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, USA.
Vanessa SerratoKnight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
C Sue RichardsDepartment of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, USA.
Paul T SpellmanDepartment of Medicine, University of California Los Angeles, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0002-4810-0022
Jackilen ShannonDivision of Oncological Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.ORCID https://orcid.org/0000-0001-5377-9511

Funding

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
OREGON CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024140 · NCRR · OREGON HEALTH & SCIENCE UNIVERSITY · PI ORWOLL, ERIC S. · 2006 to 2011
$61.1M
Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
Measuring Gender in the Healthy Oregon ProjectU01CA232819 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI SHANNON, JACKILEN, SPELLMAN, PAUL T. · 2020 to 2023
$6.3M
STEM Assessment and Reporting Tracker (START): Professional portfolio mentoring to support workforce training and longitudinal outcomes researchR25GM129840 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI MARRIOTT, LISA K · 2018 to 2022
$1.3M
CHIDR Chatter: Translating community research data forclassroom useR25OD010496 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI MARRIOTT, LISA K · 2012 to 2016
$1.3M
NCATS NIH HHS UL1 TR002369NCI NIH HHS P30 CA069533NCI NIH HHS U01 CA232819NCRR NIH HHS UL1 RR024140NIGMS NIH HHS R25 GM129840NIH HHS R25 OD010496
6 · The paper itself

Abstract

Background: Cancer health research relies on large-scale cohorts to derive generalizable results for different populations. While traditional epidemiological cohorts often use costly random sampling or self-motivated, preselected groups, a shift toward health system-based cohorts has emerged. However, such cohorts depend on participants remaining within a single system. Recent consumer engagement models using smartphone-based communication, driving projects, and social media have begun to upend these paradigms. Methods: We initiated the Healthy Oregon Project (HOP) to support basic and clinical cancer research. HOP study employs a novel, cost-effective remote recruitment approach to effectively establish a large-scale cohort for population-based studies. The recruitment leverages the unique email account, the HOP website, and social media platforms to direct smartphone users to the study app, which facilitates saliva sample collection and survey administration. Monthly newsletters further facilitate engagement and outreach to broader communities. Results: By the end of 2022, the HOP has enrolled approximately 35,000 participants aged 18-100 years (median = 44.2 years), comprising more than 1% of the Oregon adult population. Among those who have app access, ∼87% provided consent to genetic screening. The HOP monthly email newsletters have an average open rate of 38%. Efforts continue to be made to improve survey response rates. Conclusion: This study underscores the efficacy of remote recruitment approaches in establishing large-scale cohorts for population-based cancer studies. The implementation of the study facilitates the collection of extensive survey and biological data into a repository that can be broadly shared and supports collaborative clinical and translational research.

Indexed as

appCohortgeneticsHOPpopulation

Identifiers

PMID38384895
PMCPMC10880011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.